The deal got reasonable coverage - CNBC sourced from Reuters, Business Weekly UK, BioCentury, Biotech UK, SCRIP a few others all basically just reruns of the announcement with a few words mixed up much like the Nine MSN one, still early though for overseas markets might get a quick snippet from FierceBio as they follow Janssen / J&J pretty closely although no release of any figures might mute any coverage there.
If figures are going to be released (which i think is a good possibility) it's probably not quite there yet & the release today was more a move to tap something inline with guidance, as the release stated there's still ongoing discussions to finalise commercial terms so until these are completed where yet to find out - my guess would be by end of month we wil atleast know if figures/terms are being released or withheld.
On a side note though it seems most deals with large figures &/or lucrative deals formally released are often those with private companies i guess pharma feel safer in that respect that opening their book is not being manipulated or hype fed in the market.
Worth scanning channels again later tonight or in the morning though.
PYC Price at posting:
3.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)